MPZL2 and glioblastoma: On the one hand, in response to epithelial V-like antigen 1 (Eva1), the non-canonical NF-κB activator NF-κB inducing kinase (NIK) was shown to promote GBM tumorigenic and stem cell properties by increasing relB levels [75].